Home › Certara Partners With Critical Path Institute To Develop Population-Based Lung Model To Test New Tuberculosis Drugs
 

Keywords :   


Certara Partners With Critical Path Institute To Develop Population-Based Lung Model To Test New Tuberculosis Drugs

2013-10-02 05:59:57| drugdiscoveryonline News Articles

Certara, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, recently announced that it is partnering with the Critical Path Institute (“C-Path”) to develop a physiologically-based pharmacokinetic (PBPK) model of the human lung

Tags: test model partners develop

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Hurricane Isaac Graphics
28.09Hurricane Isaac Forecast Discussion Number 12
28.09Tropical Storm Joyce Graphics
28.09Hurricane Isaac Wind Speed Probabilities Number 12
28.09Hurricane Isaac Forecast Advisory Number 12
28.09Hurricane Isaac Public Advisory Number 12
28.09Summary for Hurricane Isaac (AT5/AL102024)
28.09Tropical Storm Joyce Wind Speed Probabilities Number 6
More »